Exos Asset Management’s Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 CSTA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,448
Closed -$124 190
2024
Q1
$124 Buy
+6,448
New +$202 ﹤0.01% 179

Other funds holding CSTA.WS

Exos Asset Management's CSTA.WS Position: Q2 2024 in Review

Exos Asset Management sold out of Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (CSTA.WS) in Q2 2024, closing a stake of 6,448 shares — an estimated $124 sold.

Exos Asset Management first reported a position in CSTA.WS in Q1 2024 and held it in 1 quarter. The position peaked at $124 in Q1 2024. 1 fund tracked by Wall St. Rank holds CSTA.WS as of Q2 2024.

  • Exos Asset Management reported no remaining Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2024 after selling out during the quarter.
  • Exos Asset Management sold 6,448 Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2024, an estimated $124.
  • Exos Asset Management first reported a position in Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2024 and held it in 1 quarter.
  • Exos Asset Management's Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $124 in Q1 2024.
  • 1 fund tracked by Wall St. Rank held Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2024.

Based on Exos Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.